Intense pulsed light treatment for chronic dry eye and MGD
Intense Pulsed Light (IPL) therapy is an advanced, non-invasive treatment for meibomian gland dysfunction (MGD) - one of the most common causes of chronic dry eye. By delivering precise pulses of light to the skin around the eyes, IPL reduces inflammation, improves blood vessel health, and helps restore normal oil production from the meibomian glands.
At Vale Eye Surgeons, IPL treatment is delivered by our trained staff. Your treatment plan is designed by experts who understand the full spectrum of dry eye management, ensuring high clinical standards and personalized care.
The IPL device emits controlled pulses of broadband light that target abnormal blood vessels along the eyelid margin. This reduces the inflammatory cycle that damages meibomian glands and disrupts your tear film. After each session, meibomian gland expression may also be performed to clear blocked glands and encourage healthy oil flow.
A comprehensive dry eye evaluation including meibomian gland imaging and tear film analysis to confirm IPL is the right treatment for you.
Protective eye shields are placed over your eyes, then precise light pulses are applied to the skin around the eyelids. The procedure is comfortable and takes approximately 15-20 minutes.
A typical course involves four sessions spaced several weeks apart for optimal results. Many patients notice a significant improvement in symptoms after the first session.
IPL therapy is most effective for patients with evaporative dry eye caused by meibomian gland dysfunction. It is not suitable for all skin types - your specialist will assess your suitability during your initial consultation. If IPL is not appropriate, alternative treatments will be discussed.
There is no downtime after IPL treatment. You may experience mild warmth or redness around the treated area, which typically resolves within a few hours. You can return to normal activities immediately.
Dry eye is often a symptom of meibomian gland dysfunction (MGD), where the oil-secreting glands along the eyelid margin become blocked or inflamed. It can also be associated with rosacea, blepharitis, hormonal changes (particularly in women during and after menopause), prolonged screen use, contact lens wear, and certain medications including antihistamines and antidepressants. In some cases dry eye is linked to systemic autoimmune conditions such as Sjögren’s syndrome or rheumatoid arthritis. Identifying the underlying cause is the first step to effective treatment.
Left untreated, chronic dry eye can cause persistent corneal micro-abrasions, scarring, and in severe cases, permanent damage to the corneal surface. More commonly it causes significant quality of life impairment — difficulty reading, driving, and using screens; light sensitivity; and chronic discomfort. Effective treatment protects the ocular surface and prevents long-term deterioration.
Lubricant drops provide temporary symptom relief but do not treat the underlying cause in most patients. If dry eye is driven by MGD — blocked meibomian glands producing poor-quality tear film oil — drops alone will not restore gland function. IPL therapy and professional gland expression target the root cause, reducing dependence on drops over time. Your assessment will determine whether drops, IPL, or a combination approach is most appropriate.
Many patients notice improved comfort after their first IPL session. The full benefit of a four-session course typically develops over eight to twelve weeks as gland function gradually improves. Some patients require maintenance sessions every six to twelve months. Symptom relief from lubricant drops is immediate but temporary; IPL results accumulate and can last considerably longer with appropriate aftercare.